Efficacy and Dose Ranging Study of Seroguard
Clinical trial NCT03660787 · COMPLETED
Trial details
- NCT number
- NCT03660787
- Sponsor
- Pharmasyntez
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2018-01-23
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.